Fecal Microbiota Transplant in a Patient Infected with Multidrug-Resistant Bacteria: A Case Report

Abstract: Introduction: There has been a growing interest in fecal microbiota transplantation (FMT) as a way to manipulate gut microbiota, with potential benefit in patients infected with multidrug-resistant (MDR) bacteria. Case Presentation: We present the case of an 87-year-old male with recurrent ascending cholangitis due to biliary atony and impaired biliary drainage after multiple biliary sphincterotomies and two papillary balloon dilations. In this context, a choledochoduodenostomy was performed, but the patient kept on having repeated episodes of acute cholangitis, resulting in multiple hospitalizations, every other week, with need of multiple broad-spectrum antibiotic courses, which led to bacteremias with MDR microorganisms. Several therapeutic strategies such as prophylactic antibiotics (including rifaximin), pre- and probiotics, prokinetics, and ursodeoxycholic acid were unsuccessfully attempted. After multidisciplinary case discussion, an FMT was proposed, with the aim of manipulating gut microbiota and decreasing MDR bacteremias. We first performed FMT via colonoscopy in September 2018, after which the patient still had 3 more hospitalizations for acute cholangitis, but isolated bacteria in blood cultures were resistant only to amoxicillin and clavulanic acid. Considering this apparent change in the microbial resistance profile, we performed a second FMT in January 2019 via the upper gastrointestinal route. During the next 4 months, the patient remained well. In April 2019, the patient relapsed again with three more episodes of cholangitis, for which we repeated the FMT via upper gastrointestinal endoscopy. No readmissions were observed during the next 4 months. All three FMTs were performed without complications. Discussion and Conclusion: FMT seems to be a safe procedure and was effective in decreasing hospital admissions and changing the profile of MDR bacteria previously isolated from blood cultures.

Saved in:
Bibliographic Details
Main Authors: Gouveia,Catarina, Palos,Carlos, Pereira,Patrícia, Ramos,Lídia Roque, Cravo,Marília
Format: Digital revista
Language:English
Published: Sociedade Portuguesa de Gastrenterologia 2021
Online Access:http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452021000100056
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2341-45452021000100056
record_format ojs
spelling oai:scielo:S2341-454520210001000562021-11-03Fecal Microbiota Transplant in a Patient Infected with Multidrug-Resistant Bacteria: A Case ReportGouveia,CatarinaPalos,CarlosPereira,PatríciaRamos,Lídia RoqueCravo,Marília Fecal microbiota transplantation Multidrug-resistant bacteria Recurrent cholangitis Abstract: Introduction: There has been a growing interest in fecal microbiota transplantation (FMT) as a way to manipulate gut microbiota, with potential benefit in patients infected with multidrug-resistant (MDR) bacteria. Case Presentation: We present the case of an 87-year-old male with recurrent ascending cholangitis due to biliary atony and impaired biliary drainage after multiple biliary sphincterotomies and two papillary balloon dilations. In this context, a choledochoduodenostomy was performed, but the patient kept on having repeated episodes of acute cholangitis, resulting in multiple hospitalizations, every other week, with need of multiple broad-spectrum antibiotic courses, which led to bacteremias with MDR microorganisms. Several therapeutic strategies such as prophylactic antibiotics (including rifaximin), pre- and probiotics, prokinetics, and ursodeoxycholic acid were unsuccessfully attempted. After multidisciplinary case discussion, an FMT was proposed, with the aim of manipulating gut microbiota and decreasing MDR bacteremias. We first performed FMT via colonoscopy in September 2018, after which the patient still had 3 more hospitalizations for acute cholangitis, but isolated bacteria in blood cultures were resistant only to amoxicillin and clavulanic acid. Considering this apparent change in the microbial resistance profile, we performed a second FMT in January 2019 via the upper gastrointestinal route. During the next 4 months, the patient remained well. In April 2019, the patient relapsed again with three more episodes of cholangitis, for which we repeated the FMT via upper gastrointestinal endoscopy. No readmissions were observed during the next 4 months. All three FMTs were performed without complications. Discussion and Conclusion: FMT seems to be a safe procedure and was effective in decreasing hospital admissions and changing the profile of MDR bacteria previously isolated from blood cultures.info:eu-repo/semantics/openAccessSociedade Portuguesa de GastrenterologiaGE-Portuguese Journal of Gastroenterology v.28 n.1 20212021-02-01info:eu-repo/semantics/reporttext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452021000100056en10.1159/000507263
institution SCIELO
collection OJS
country Portugal
countrycode PT
component Revista
access En linea
databasecode rev-scielo-pt
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Gouveia,Catarina
Palos,Carlos
Pereira,Patrícia
Ramos,Lídia Roque
Cravo,Marília
spellingShingle Gouveia,Catarina
Palos,Carlos
Pereira,Patrícia
Ramos,Lídia Roque
Cravo,Marília
Fecal Microbiota Transplant in a Patient Infected with Multidrug-Resistant Bacteria: A Case Report
author_facet Gouveia,Catarina
Palos,Carlos
Pereira,Patrícia
Ramos,Lídia Roque
Cravo,Marília
author_sort Gouveia,Catarina
title Fecal Microbiota Transplant in a Patient Infected with Multidrug-Resistant Bacteria: A Case Report
title_short Fecal Microbiota Transplant in a Patient Infected with Multidrug-Resistant Bacteria: A Case Report
title_full Fecal Microbiota Transplant in a Patient Infected with Multidrug-Resistant Bacteria: A Case Report
title_fullStr Fecal Microbiota Transplant in a Patient Infected with Multidrug-Resistant Bacteria: A Case Report
title_full_unstemmed Fecal Microbiota Transplant in a Patient Infected with Multidrug-Resistant Bacteria: A Case Report
title_sort fecal microbiota transplant in a patient infected with multidrug-resistant bacteria: a case report
description Abstract: Introduction: There has been a growing interest in fecal microbiota transplantation (FMT) as a way to manipulate gut microbiota, with potential benefit in patients infected with multidrug-resistant (MDR) bacteria. Case Presentation: We present the case of an 87-year-old male with recurrent ascending cholangitis due to biliary atony and impaired biliary drainage after multiple biliary sphincterotomies and two papillary balloon dilations. In this context, a choledochoduodenostomy was performed, but the patient kept on having repeated episodes of acute cholangitis, resulting in multiple hospitalizations, every other week, with need of multiple broad-spectrum antibiotic courses, which led to bacteremias with MDR microorganisms. Several therapeutic strategies such as prophylactic antibiotics (including rifaximin), pre- and probiotics, prokinetics, and ursodeoxycholic acid were unsuccessfully attempted. After multidisciplinary case discussion, an FMT was proposed, with the aim of manipulating gut microbiota and decreasing MDR bacteremias. We first performed FMT via colonoscopy in September 2018, after which the patient still had 3 more hospitalizations for acute cholangitis, but isolated bacteria in blood cultures were resistant only to amoxicillin and clavulanic acid. Considering this apparent change in the microbial resistance profile, we performed a second FMT in January 2019 via the upper gastrointestinal route. During the next 4 months, the patient remained well. In April 2019, the patient relapsed again with three more episodes of cholangitis, for which we repeated the FMT via upper gastrointestinal endoscopy. No readmissions were observed during the next 4 months. All three FMTs were performed without complications. Discussion and Conclusion: FMT seems to be a safe procedure and was effective in decreasing hospital admissions and changing the profile of MDR bacteria previously isolated from blood cultures.
publisher Sociedade Portuguesa de Gastrenterologia
publishDate 2021
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452021000100056
work_keys_str_mv AT gouveiacatarina fecalmicrobiotatransplantinapatientinfectedwithmultidrugresistantbacteriaacasereport
AT paloscarlos fecalmicrobiotatransplantinapatientinfectedwithmultidrugresistantbacteriaacasereport
AT pereirapatricia fecalmicrobiotatransplantinapatientinfectedwithmultidrugresistantbacteriaacasereport
AT ramoslidiaroque fecalmicrobiotatransplantinapatientinfectedwithmultidrugresistantbacteriaacasereport
AT cravomarilia fecalmicrobiotatransplantinapatientinfectedwithmultidrugresistantbacteriaacasereport
_version_ 1756004340697399296